HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara L Pressel Selected Research

Chlorthalidone (Chlortalidone)

10/2019Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program.
1/2018The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications.
4/2017Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
1/2017Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
1/2016Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).
11/2014Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
7/2014Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.
3/2012Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.
1/2012Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
12/2011Association between chlorthalidone treatment of systolic hypertension and long-term survival.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara L Pressel Research Topics

Disease

20Myocardial Infarction
04/2017 - 11/2006
12Hypertension (High Blood Pressure)
04/2017 - 11/2006
10Stroke (Strokes)
10/2019 - 04/2008
9Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 05/2009
6Heart Failure
01/2016 - 05/2009
5Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 09/2008
5Coronary Disease (Coronary Heart Disease)
01/2016 - 11/2006
4Isolated Systolic Hypertension
10/2019 - 01/2005
3Diabetes Mellitus
02/2010 - 11/2006
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2016
2Dyslipidemias (Dyslipidemia)
10/2013 - 09/2008
2Chronic Renal Insufficiency
10/2013 - 07/2010
1Albuminuria
01/2019
1Essential Hypertension
01/2018
1Hyperlipidemias (Hyperlipidemia)
01/2017
1Hemolysis
01/2016
1Reperfusion Injury
01/2016
1Peripheral Arterial Disease
11/2014
1Neoplasms (Cancer)
08/2014
1Renal Insufficiency (Renal Failure)
07/2014
1Overweight
07/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2010
1Proteinuria
09/2008
1Kidney Diseases (Kidney Disease)
09/2008
1Transient Ischemic Attack
04/2008

Drug/Important Bio-Agent (IBA)

25Antihypertensive Agents (Antihypertensives)IBA
10/2019 - 11/2006
21LipidsIBA
01/2019 - 11/2006
15Chlorthalidone (Chlortalidone)FDA LinkGeneric
10/2019 - 01/2005
12DiureticsIBA
04/2017 - 01/2005
11Lisinopril (Prinivil)FDA LinkGeneric
01/2018 - 11/2006
11Amlodipine (Norvasc)FDA LinkGeneric
01/2018 - 11/2006
8ThiazidesIBA
01/2017 - 11/2006
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2017 - 11/2006
7Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2017 - 11/2006
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017 - 09/2008
4Pravastatin (Pravachol)FDA LinkGeneric
01/2017 - 09/2008
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 11/2006
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2017 - 07/2010
1Insulin (Novolin)FDA Link
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1HDL CholesterolIBA
01/2019
1Atorvastatin (Lipitor)FDA Link
01/2016
1AlbuminsIBA
01/2016
1CreatinineIBA
01/2016
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2016
1IronIBA
01/2016
1Biomarkers (Surrogate Marker)IBA
08/2014
1CalciumIBA
07/2010
1Pharmaceutical PreparationsIBA
05/2009
1Doxazosin (Cardura)FDA LinkGeneric
05/2009
1CholesterolIBA
09/2008
1LDL CholesterolIBA
09/2008
1HDL LipoproteinsIBA
09/2008
1Blood Glucose (Blood Sugar)IBA
11/2006

Therapy/Procedure

13Therapeutics
04/2017 - 01/2005